584
Views
0
CrossRef citations to date
0
Altmetric
Journal Club

A new predictive tool for postoperative radiotherapy in prostate cancer

&
Pages 277-278 | Received 01 Mar 2017, Accepted 19 Mar 2017, Published online: 27 Apr 2017

References

  • Sharma S, Zapatero-Rodriguez J, O'Kennedy R. Prostate cancer diagnostics: Clinical challenges and the ongoing need for disruptive and effective diagnostic tools. Biotechnol Adv 2016; 35:135–49; PMID:27939303; https://doi.org/10.1016/j.biotechadv.2016.11.009
  • Gomella LG. Addressing the needs of the high-risk prostate cancer patient. Rev Urol 2005; 7 Suppl 5:S18-28; PMID:16985880
  • Kwon O, Kim KB, Lee YI, Byun SS, Kim JS, Lee SE, Hong SK. Salvage radiotherapy after radical prostatectomy: prediction of biochemical outcomes. PLoS One 2014; 9(7):e103574; PMID:25072938; https://doi.org/10.1371/journal.pone.0103574
  • Bartkowiak D, Bottke D, Wiegel T. Radiotherapy in the management of prostate cancer after radical prostatectomy. Future Oncol 2013; 9(5):669-79; PMID:23647296; https://doi.org/10.2217/fon.13.3
  • Darwish OM, Raj GV. Management of biochemical recurrence after primary localized therapy for prostate cancer. Front Oncol 2012; 2:48; PMID:22655274; https://doi.org/10.3389/fonc.2012.00048
  • Farr A, Wuerstlein R, Heiduschka A, Singer CF, Harbeck N. Modern risk assessment for individualizing treatment concepts in Early-stage breast cancer. Rev Obstet Gynecol 2013; 6(3-4):165-73; PMID:24920978
  • Marrone M, Potosky AL, Penson D, Freedman AN. A 22 Gene-expression Assay, Decipher(R) (GenomeDx Biosciences) to Predict Five-year risk of metastatic prostate cancer in men treated with radical prostatectomy. PLoS Curr 2015; 7; PMID:26664778; https://doi.org/10.1371/currents.eogt.761b81608129ed61b0b48d42c04f92a4
  • Cuzick J, Berney DM, Fisher G, Mesher D, Møller H, Reid JE, Perry M, Park J, Younus A, Gutin A, et al. Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort. Br J Cancer 2012; 106(6):1095-9; PMID:22361632; https://doi.org/10.1038/bjc.2012.39
  • Cooperberg MR, Hilton JF, Carroll PR. The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy. Cancer 2011; 117(22):5039-46; PMID:21647869; https://doi.org/10.1002/cncr.26169
  • Zhao SG, Chang SL, Spratt DE, Erho N, Yu M, Ashab HA, Alshalalfa M, Speers C, Tomlins SA, Davicioni E, et al. Development and validation of a 24 gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis. Lancet Oncol 2016; 17(11):1612-1620; PMID:27743920; https://doi.org/10.1016/S1470-2045(16)30491-0

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.